What is the market capitalization of Absci Corporation?

Absci Corporation (ABSI) has a market capitalization of approximately 926,076,033 USD.

How many ETFs hold ABSI?

ABSI is held by 19 ETFs tracked on Investir en Bourse.

Where can I buy ABSI in Canada?

ABSI can be purchased through any Canadian online broker including Wealthsimple, Questrade, Qtrade, or RBC Direct Investing.

ABSI

Absci Corporation

Absci Corporation (ABSI) is an American company in the healthcare sector, listed on NASDAQ. Market capitalization of 926 million USD (small-cap).

Details

Price5.94 USD

Market cap926.08 M USD

Payout ratio0.00%

ROE-63.89%

Debt / Equity2.57%

SectorHealthcare

Websiteabsci.com

Updated a few minutes ago

Absci Corporation, a clinical-stage biopharmaceutical company, develops various antibody therapeutics in the United States. Its preclinical development programs include ABS-101, which is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; ABS-201, an anti-prolactin receptor (PRLR) antibody, which is phase 1/2a clinical trial for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, Owkin, Oracle Corporation, and Advanced Micro Devices, Inc. for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington.